Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19 vaccine effectiveness and reactogenicity in Osaka geriatric intermediate care facilities
jRCT1051200148Completed
- Start
- Mar 2021
- Countries
- 1
01
Overview
Open-label trial in coronavirus disease 2019 (COVID-19) (2 arms). Primary endpoint: Immunogenicity. Started Mar 2021; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT1051200148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051200148.